Clinical trial
Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke
NCT00005883 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00005883 |
|---|---|
| Title | Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke |
| Official title | A Phase I - Part B Multiple Dose Trial of Phenethyl Isothiocyanate |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | phenethyl isothiocyanate |
| Primary completion | Apr 1, 2001 |
| First posted | Apr 28, 2004 |
| Last update posted | Mar 28, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: